2006
DOI: 10.1016/s1386-6532(06)70009-9
|View full text |Cite
|
Sign up to set email alerts
|

Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein—Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
49
0
8

Year Published

2010
2010
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 66 publications
(58 citation statements)
references
References 29 publications
1
49
0
8
Order By: Relevance
“…An antibody titer is used to measure of how much antibody that recognizes a particular epitope (Kogelnik, et al, 2006). Positive control that derived from standard protein of GAD65 ELISA kit was highest intensity among of all ( Figure 3B).…”
Section: Discussionmentioning
confidence: 99%
“…An antibody titer is used to measure of how much antibody that recognizes a particular epitope (Kogelnik, et al, 2006). Positive control that derived from standard protein of GAD65 ELISA kit was highest intensity among of all ( Figure 3B).…”
Section: Discussionmentioning
confidence: 99%
“…These findings must, however, be interpreted carefully since using acyclovir to treat EBV infection is questionable (personal data). In another study, valgancyclovir, an oral pro-drug of ganciclovir, was used to treat CFS patients with high EBV antibody titers (Kogelnik et al, 2006;Lerner et al, 2001). Clinical improvement was observed with a decrease in EBV antibody titer.…”
Section: Herpes Virus and Cfsmentioning
confidence: 99%
“…60 Unassembled EBVencoded early proteins, including among others, EBV DNA polymerase and EBV dUTPase, may enter the periphery in both the IM and EBV subsets of CFS. We postulate that these circulating EBV-encoded abortive lytic proteins attach to cellular membranes and enter multiple organs, including the heart (cardiomyopathy), 6,24 muscle (myositis), brain, and meninges (encephalopathy), 8 and subsequently incite an explosive inflammatory response-producing disease. 61 Symptoms and pathologic findings in the IM and EBV subsets of CFS may require the same circulating EBV-encoded proteins.…”
Section: 55mentioning
confidence: 99%
“…5,6 In three peer-reviewed publications, including a placebo-controlled trial and a recent systematic review, we report longlasting clinical improvement with valacyclovir in Epstein-Barr virus (EBV) subset of CFS patients. 1,[12][13][14] Kogelnik et al have reported similar therapeutic results in human herpesvirus (HHV) 6/EBV subset group-A CFS with valganciclovir, 8 and Jason et al estimate there are 800,000 CFS patients in the USA. 15,16 CFS remains a conundrum.…”
mentioning
confidence: 99%